Almost one year in, ApconiX is going from strength to strength in delivering integrated toxicology expertise. But we realised we had a few key skills missing; to address this we have brought in 3 new toxicology experts.
Mike O’Donovan joins us to provide expertise in genetic toxicology. With over 35 years’ experience in the pharmaceutical industry and has over 65 peer-reviewed publications, Mike has an international reputation as a senior toxicologist.
Damian Deavall joins us to provide broad expertise in global drug development across multiple modalities. He specialises in leading and managing drug safety programmes, especially within complex alliances and partnerships.
Jay Goodman joins us to strengthen our depth of experience in mechanisms underlying the ability of non-genotoxic compounds to cause carcinogenesis. Jay is internationally renowned for his research activities and his long-standing interest in furthering science-based safety assessment of chemicals.
We look forward to working with them and to another exciting year ahead!
By Ruth Roberts|2023-01-18T15:28:51+00:00May 17th, 2016|Careers|Comments Off on ApconiX Welcomes 3 New Experts!
Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath. A co-founder of ApconiX, Ruth has 25 years of experience in leading roles in drug safety within large pharma. Ruth is also Chair and Director of Drug Discovery at The University of Birmingham, UK and was previously Global Head of Regulatory Safety at AstraZeneca. With over 140 publications in peer-reviewed journals, she is former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and President of the Academy of Toxicological Sciences. Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development.